Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Dacarbazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 68 Hodgkin Disease 49 Lymphoma 19 Sarcoma 13 Neoplasm Metastasis 10 Leiomyosarcoma 8 Skin Neoplasms 6 Neoplasms 6 Uveal Melanoma 5 Sarcoma, Synovial 3 Recurrence 3 Solitary Fibrous Tumors 2 Sarcoma, Alveolar Soft Part 2 Neuroblastoma 2 Thyroid Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Parathyroid Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Melanoma Neoplasms 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Liposarcoma 1

Interventions

Diathermy 18 Radiotherapy 10 Drug Therapy 5 Cisplatin 5 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Doxorubicin 2 Conization 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Therapeutics 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡